Encompass Hospice Of Tennessee 545 Mainstream Drive Ste #413, Nashville, TN, 37228 | |
(615) 733-3600 |
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
Name | Encompass Hospice Of Tennessee |
---|---|
Location | 545 Mainstream Drive Ste #413, Nashville, Tennessee |
Hospice ID | 441598 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 180 |
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
NPI Number | 1538541404 |
Organization Name | Adoration Hospice, Llc |
Address | 545 Mainstream Dr Nashville, Tennessee, 37228 |
Phone Number | (615)733-3600 |
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
NPI Number | 1730318619 |
Organization Name | A Touch Of Grace Hospice Of Nashville, Llc |
Address | 545 Mainstream Dr Nashville, Tennessee, 37228 |
Phone Number | (615)733-3600 |
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
NPI Number | 1881953032 |
Organization Name | Hospice Advantage, Llc. |
Address | 545 Mainstream Dr Nashville, Tennessee, 37228 |
Phone Number | (615)733-3600 |
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
NPI Number | 1952746844 |
Organization Name | Hospice Advantage, Llc |
Address | 545 Mainstream Dr Nashville, Tennessee, 37228 |
Phone Number | (615)733-3600 |
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
NPI Number | 1992189898 |
Organization Name | Adoration Hospice, Llc |
Address | 545 Mainstream Dr Nashville, Tennessee, 37228 |
Phone Number | (615)733-3600 |
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
Home Health Aides | 1 |
Counselors | 1 |
Licensed Practical or Vocational Nurses | 0.25 |
Medical Social Workers | 0.5 |
Registered Nurses | 1.25 |
Other Personnel | 0.5 |
Total Employees | 4.5 |
---|
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
Others | 2 |
Total Volunteers | 2 |
---|
News Archive
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Researchers at the Syracuse Veterans Affairs Medical Center in New York examined postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel and found that the postpolypectomy bleeding rate is significantly higher in patients undergoing polypectomy while taking clopidogrel and concomitant aspirin/nonsteroidal anti-inflammatory drugs, but that the risk is small and the outcome is favorable.
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.
› Verified 8 days ago
Alive Hospice Inc Location: 1718 Patterson Road, Nashville, Tennessee, 37203 Phone: (615) 733-3600 |
Aseracare Hospice - Nashville Location: 441 Donelson Pike, Suite 400, Nashville, Tennessee, 37214 Phone: (615) 733-3600 |
Avalon Hospice Location: 2525 Perimeter Place Drive, Suite 105, Nashville, Tennessee, 37214 Phone: (615) 733-3600 |
Gentiva Hospice Location: 1400 Donelson Pike Suite B5, Nashville, Tennessee, 37217 Phone: (615) 733-3600 |